Archive: 28/07/2015

Hikma buys US generic drugmaker Roxane for $2.65bn

London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector's latest rapid round of consolidation.

page 8 from 9